MAP3K10
Mitogen-activated protein kinase kinase kinase 10
Also known as: M3K10_HUMAN, MEKK10, MLK2, MST
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02779
- Gene
- MAP3K10
- Ensembl
- ENSG00000130758
- Chromosome
- 19
- Canonical length
- 954 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Actin filaments,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase has been shown to activate MAPK8/JNK and MKK4/SEK1, and this kinase itself can be phoshorylated, and thus activated by JNK kinases. This kinase functions preferentially on the JNK signaling pathway, and is reported to be involved in nerve growth factor (NGF) induced neuronal apoptosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
954 residues, UniProt reviewed canonical sequence.
>Q02779|MAP3K10
1 MEEEEGAVAK EWGTTPAGPV WTAVFDYEAA GDEELTLRRG DRVQVLSQDC AVSGDEGWWT
61 GQLPSGRVGV FPSNYVAPGA PAAPAGLQLP QEIPFHELQL EEIIGVGGFG KVYRALWRGE
121 EVAVKAARLD PEKDPAVTAE QVCQEARLFG ALQHPNIIAL RGACLNPPHL CLVMEYARGG
181 ALSRVLAGRR VPPHVLVNWA VQVARGMNYL HNDAPVPIIH RDLKSINILI LEAIENHNLA
241 DTVLKITDFG LAREWHKTTK MSAAGTYAWM APEVIRLSLF SKSSDVWSFG VLLWELLTGE
301 VPYREIDALA VAYGVAMNKL TLPIPSTCPE PFARLLEECW DPDPHGRPDF GSILKRLEVI
361 EQSALFQMPL ESFHSLQEDW KLEIQHMFDD LRTKEKELRS REEELLRAAQ EQRFQEEQLR
421 RREQELAERE MDIVERELHL LMCQLSQEKP RVRKRKGNFK RSRLLKLREG GSHISLPSGF
481 EHKITVQASP TLDKRKGSDG ASPPASPSII PRLRAIRLTP VDCGGSSSGS SSGGSGTWSR
541 GGPPKKEELV GGKKKGRTWG PSSTLQKERV GGEERLKGLG EGSKQWSSSA PNLGKSPKHT
601 PIAPGFASLN EMEEFAEAED GGSSVPPSPY STPSYLSVPL PAEPSPGARA PWEPTPSAPP
661 ARWGHGARRR CDLALLGCAT LLGAVGLGAD VAEARAADGE EQRRWLDGLF FPRAGRFPRG
721 LSPPARPHGR REDVGPGLGL APSATLVSLS SVSDCNSTRS LLRSDSDEAA PAAPSPPPSP
781 PAPTPTPSPS TNPLVDLELE SFKKDPRQSL TPTHVTAACA VSRGHRRTPS DGALGQRGPP
841 EPAGHGPGPR DLLDFPRLPD PQALFPARRR PPEFPGRPTT LTFAPRPRPA ASRPRLDPWK
901 LVSFGRTLTI SPPSRPDTPE SPGPPSVQPT LLDMDMEGQN QDSTVPLCGA HGSHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP3K10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 74 nTPM
- hippocampal formation: 64 nTPM
- amygdala: 62 nTPM
- basal ganglia: 45 nTPM
- cerebellum: 32 nTPM
- hypothalamus: 23 nTPM
Single-cell type
- bergmann glia: 27 nCPM
- brain excitatory neurons: 25 nCPM
- retinal ganglion cells: 23 nCPM
- retinal amacrine cells: 23 nCPM
- gonadotrophs: 22 nCPM
- brain inhibitory neurons: 22 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 175 nTPM
- hippocampal formation: 160 nTPM
- amygdala: 128 nTPM
- basal ganglia: 109 nTPM
- white matter: 102 nTPM
- thalamus: 79 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.59
- gnomAD missense Z
- 2.95
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- JNK cascade
- negative regulation of DNA-binding transcription factor activity
- negative regulation of DNA-templated transcription
- peptidyl-serine phosphorylation
- peptidyl-threonine phosphorylation
- positive regulation of apoptotic process
- positive regulation of JNK cascade
- positive regulation of JUN kinase activity
- protein autophosphorylation
- signal transduction
- smoothened signaling pathway
Molecular functions
- ATP binding
- bHLH transcription factor binding
- JUN kinase kinase kinase activity
- protein homodimerization activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Mitogen-activated protein (MAP) kinase kinase kinase, MLK1-4
- Protein kinase, ATP binding site
- MLK1-3, SH3 domain
- SH3-like domain superfamily
- Serine/Threonine Kinases and Pseudokinases
- Protein tyrosine and serine/threonine kinase
- Variant SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP3K10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP3K10 as an antibody target. Whether an autoantibody or antibody against MAP3K10 could matter depends on whether native MAP3K10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP3K10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP3K10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...